Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

[Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies].

Yun HW, Shim KN.

Korean J Gastroenterol. 2013 Jun;61(6):303-6. Review. Korean.

PMID:
23877209
[PubMed - indexed for MEDLINE]
Free Article
2.

Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.

Smyth EC, Shah MA.

World J Gastroenterol. 2011 Dec 14;17(46):5059-74. doi: 10.3748/wjg.v17.i46.5059. Review.

PMID:
22171140
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

PET and PET-CT in esophageal and gastric cancer.

Wieder HA, Krause BJ, Herrmann K.

Methods Mol Biol. 2011;727:59-76. doi: 10.1007/978-1-61779-062-1_5.

PMID:
21331929
[PubMed - indexed for MEDLINE]
4.

A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.

Smyth E, Schöder H, Strong VE, Capanu M, Kelsen DP, Coit DG, Shah MA.

Cancer. 2012 Nov 15;118(22):5481-8. doi: 10.1002/cncr.27550. Epub 2012 May 1.

PMID:
22549558
[PubMed - indexed for MEDLINE]
Free Article
5.

Gastrointestinal tract malignancies and positron emission tomography: an overview.

Esteves FP, Schuster DM, Halkar RK.

Semin Nucl Med. 2006 Apr;36(2):169-81. Review.

PMID:
16517238
[PubMed - indexed for MEDLINE]
6.

Positron emission tomography in the staging of esophageal cancer.

Leccisotti L.

Rays. 2006 Jan-Mar;31(1):9-12. Review.

PMID:
16999368
[PubMed - indexed for MEDLINE]
7.

Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.

Shimada H, Okazumi S, Koyama M, Murakami K.

Gastric Cancer. 2011 Mar;14(1):13-21. doi: 10.1007/s10120-011-0017-5. Epub 2011 Feb 18. Review.

PMID:
21331531
[PubMed - indexed for MEDLINE]
8.

Evolving role of (18)F-fluorodeoxyglucose positron emission tomography in the management of esophageal carcinoma.

Dam HQ, Manzone TM, Sagar VV.

Surg Oncol Clin N Am. 2006 Oct;15(4):733-49. Review.

PMID:
17030270
[PubMed - indexed for MEDLINE]
9.

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.

Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L.

J Clin Oncol. 2000 Sep 15;18(18):3202-10.

PMID:
10986052
[PubMed - indexed for MEDLINE]
10.

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.

Chowdhury FU, Bradley KM, Gleeson FV.

Clin Radiol. 2008 Dec;63(12):1297-309. doi: 10.1016/j.crad.2008.05.010. Epub 2008 Aug 21. Review.

PMID:
18996259
[PubMed - indexed for MEDLINE]
11.

Neoplasms of the esophagus and stomach.

Dehdashti F, Siegel BA.

Semin Nucl Med. 2004 Jul;34(3):198-208. Review.

PMID:
15202101
[PubMed - indexed for MEDLINE]
12.

Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer.

Larson SM, Schoder H, Yeung H.

Cancer J. 2004 Jul-Aug;10(4):243-50. Review.

PMID:
15383205
[PubMed - indexed for MEDLINE]
13.

18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.

Chin BB, Wahl RL.

Gut. 2003 Jun;52 Suppl 4:iv23-9. Review.

PMID:
12746265
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The efficacy of FDG-PET for the management of esophageal cancer: review article.

Kato H, Nakajima M.

Ann Thorac Cardiovasc Surg. 2012;18(5):412-9. Epub 2012 Jun 15. Review.

PMID:
22785452
[PubMed - indexed for MEDLINE]
Free Article
15.

[Usefulness of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in evaluation of gastric cancer stage].

Yoon NR, Park JM, Jung HS, Cho YK, Lee IS, Choi MG, Chung IS, Song KY, Park CH.

Korean J Gastroenterol. 2012 May;59(5):347-53. Korean.

PMID:
22617528
[PubMed - indexed for MEDLINE]
Free Article
16.

The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction.

Yoon HH, Lowe VJ, Cassivi SD, Romero Y.

Gastroenterol Clin North Am. 2009 Mar;38(1):105-20, ix. doi: 10.1016/j.gtc.2009.01.007. Review.

PMID:
19327570
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.

Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.

Clin Nucl Med. 2000 Nov;25(11):882-7.

PMID:
11079584
[PubMed - indexed for MEDLINE]
18.

Positron emission tomography for prostate, bladder, and renal cancer.

Schöder H, Larson SM.

Semin Nucl Med. 2004 Oct;34(4):274-92. Review.

PMID:
15493005
[PubMed - indexed for MEDLINE]
19.

[Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].

Pifarré-Montaner P, Fernández-León A, de Juan R, del Ama-Salvador ME, Galán M, Gámez-Cenzano C, Sans M.

Rev Esp Med Nucl. 2009 May-Jun;28(3):101-5. Spanish.

PMID:
19558949
[PubMed - indexed for MEDLINE]
20.

Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.

Kim YK, Lee KW, Cho SY, Han SS, Kim SH, Kim SK, Park SJ.

Liver Transpl. 2010 Jun;16(6):767-72. doi: 10.1002/lt.22069.

PMID:
20517911
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk